Momentis Surgical’s Anovo Becomes First Triple-Approach Robot
FORT LAUDERDALE, Fla. & TEL AVIV, Israel, July 23, 2026 Momentis Surgical has received U.S. Food and Drug Administration...
AI diagnostics
Advertisement
MolecuLight Reports First Clinical Evidence for Fluorescence Imaging
PITTSBURGH, USA & BIRMINGHAM, UK, July 23, 2026 MolecuLight and The Royal Orthopaedic Hospital NHS Foundation Trust (ROH) have...
VELMENI Secures FDA 510(k) for AI-Powered 3D CBCT Imaging
SUNNYVALE, Calif., July 23, 2026 VELMENI AI has received U.S. Food and Drug Administration (FDA) 510(k) clearance for VELMENI...
Ibex Medical Analytics Strengthens Breast Cancer AI with CE-IVDR Approval
Boston and Tel Aviv, Israel, July 23, 2026 Ibex Medical Analytics announced it has received CE-IVDR certification for Ibex...
Spectral AI Names Darcy Bajko Launch Leader
DALLAS, July 8, 2026 Spectral AI, Inc. announced the appointment of Darcy Bajko as Chief Commercial Officer, effective July...
Advertisements
Renalytix KidneyIntelX® Delivers Strong Two-Year DKD Outcomes
NEW YORK, June 30, 2026 Renalytix PLC has announced the publication of groundbreaking two-year real-world evidence (RWE) demonstrating that...
Edgewise Reports Positive Phase 2 EDG-7500 HCM Data
BOULDER, Colo., June 16, 2026 Edgewise Therapeutics has announced positive top-line results from the 12-week Phase 2 CIRRUS-HCM trial...
Castle TissueCypher Surpasses 100,000 Orders in Barrett’s
FRIENDSWOOD, Texas, June 16, 2026 Castle Biosciences has announced that its TissueCypher® Barrett’s Esophagus Test has surpassed 100,000 clinical...
DELFI Diagnostics Secures New York Approval for AI-Powered Lung Cancer Blood Test
PALO ALTO, California, May 28, 2026 DELFI Diagnostics has achieved a significant regulatory milestone after receiving a Clinical Laboratory...
Subtle Medical Gains FDA Clearance for SubtleHD PET
MENLO PARK, Calif., May 27, 2026 Subtle Medical, a leading developer of AI-powered medical imaging software, has announced that...
Advertisement
